The reference listed drugs selected by China National Medical Products Administration (NMPA) are reference products to which generic drugs should be equivalent in quality and therapeutic efficacy.
Related resource: Generic Drug Registration Application (ANDA) in China
| No. | Drug Name | Dosage Form | Brand Name | Strength | MAH | Note 1 | Note 2 | Batch |
| 79-51 | view | view | Venclexta | view | AbbVie Inc. | Original drug not imported to China | US Orange Book | The 79th Batch of Reference Listed Drugs |
| 79-52 | view | view | / | view | NOVAST LABORATORIES LTD | / | US Orange Book | The 79th Batch of Reference Listed Drugs |
| 79-53 | view | view | / | view | NOVAST LABORATORIES LTD | Internationally recognized to be equivalent to the original drug | US Orange Book | The 79th Batch of Reference Listed Drugs |
| 79-54 | view | view | / | view | Fresenius Kabi USA, LLC | Original drug not imported to China | US Orange Book | The 79th Batch of Reference Listed Drugs |
| 79-55 | view | view | CARDURA | view | Viatris Pharma S.R.L | Original drug not imported to China | Approved in EU | The 79th Batch of Reference Listed Drugs |
| 79-56 | view | view | CARDURA | view | Viatris Pharma S.R.L | Original drug not imported to China | Approved in EU | The 79th Batch of Reference Listed Drugs |
| 79-57 | view | view | Minirin | view | Ferring AG | Original drug not imported to China | Approved in Switzerland | The 79th Batch of Reference Listed Drugs |
| 79-58 | view | view | Differin | view | Galderma International | Original drug not imported to China | Approved in EU | The 79th Batch of Reference Listed Drugs |
| 79-59 | view | view | Prevymis | view | Merck Sharp & Dohme B.V. | Original drug not imported to China | Approved in EU | The 79th Batch of Reference Listed Drugs |
| 79-60 | view | view | Prevymis | view | Merck Sharp & Dohme B.V. | Original drug not imported to China | Approved in EU | The 79th Batch of Reference Listed Drugs |
